GLPG
Galapagos N.V.
NASDAQ · Healthcare · Biotechnology · BE
$27.98
+1.71%Institutional positioning
13F filings over the trailing two quarters
New 26Increased 59Reduced 57Sold out 22
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Unchanged | 16,707,477 | Aug 3, 2026 |
| GILEAD SCIENCES, INC. | Unchanged | 16,707,477 | May 8, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Reduced | 3,785,991 | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 3,785,991 | Aug 14, 2026 |
| Madison Avenue Partners, LP | Increased | 3,447,807 | Aug 14, 2026 |
| MADISON AVENUE PARTNERS, LP | Increased | 2,465,179 | May 15, 2026 |
| Prosight Management, LP | Increased | 2,043,344 | Aug 14, 2026 |
| EcoR1 Capital, LLC | Unchanged | 1,667,119 | Aug 14, 2026 |
| ECOR1 CAPITAL, LLC | Unchanged | 1,667,119 | May 15, 2026 |
| PROSIGHT MANAGEMENT, LP | Increased | 1,550,000 | May 15, 2026 |
| AMERIPRISE FINANCIAL INC | Reduced | 1,424,674 | Jul 17, 2026 |
| AMERIPRISE FINANCIAL INC | Reduced | 1,272,249 | Aug 14, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 600,986 | Aug 14, 2026 |
| DME Capital Management, LP | Unchanged | 482,746 | Aug 14, 2026 |
| DME CAPITAL MANAGEMENT, LP | Unchanged | 482,746 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings